# Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ustekinumab-dose-escalation-improves-clinical-responses-in-refractory-crohn-s/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Syedreza A. Haider,Abhijeet Yadav,Courtney Perry,Leon Su,Olalekan Akanbi,Praneeth Kudaravalli,Nishant Tripathi,Mahmoud Hashim,Mohammed Khalifa Abdelsalam,M. A. Hussein,Ahmed Elkheshen,Vihang Patel,Saad Emhmed Ali,Latoya Lamb,Karen Ingram,Casie Mayne,Amy Stuffelbeam,Deborah Flomenhoft,Arnold J. Stromberg,Terrence A. Barrett |
| Citations | 38 |
| DOI | 10.1177/1756284820959245 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1177/1756284820959245 |
| OpenAlex ID | https://openalex.org/W3092878768 |
| PMID | 33133239 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Praneeth Kudaravalli](https://scholariq.org/researchers/praneeth-kudaravalli/)

## Paper journal

- [Therapeutic Advances in Gastroenterology](https://scholariq.org/journals/therapeutic-advances-in-gastroenterology/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.